Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_assertion type Assertion NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_head.
- NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_assertion wasGeneratedBy ECO_0000203 NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_provenance.
- NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_assertion wasDerivedFrom befree-2016 NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_provenance.
- NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_assertion SIO_000772 21210765 NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_provenance.
- NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_assertion evidence source_evidence_literature NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_provenance.
- NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_assertion description "[Thus, the present study has identified RECQL5 as a major determinant for CPT resistance in colorectal cancer cells and a potential candidate as a biomarker for irinotecan-based treatment for colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863495.RAZppd2TIgUrSKGr-IZ-uT4t9fUYdImeS79Jsi0fZW4wk130_provenance.